Merus merus.nl


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, referred to as Biclonics. Biclonics are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have several of the same features of conventional IgG-based antibodies, such as long half-life and low immunogenicity. Merus's lead Biclonics product candidate, MCLA-128 is being evaluated in a Phase 1/2 clinical tria...Show all

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, referred to as Biclonics. Biclonics are based on the full-length IgG format, are manufactured using industry standard processes and have been ob...Show all

Company (IPO / Went public)

Phone: +31 (0)30 253 8800

Fax:

Padualaan 8

Utrecht, 3584 CH
Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Merus $200.5M May 19, 2016
HNC Software $0M May 2, 2002
Cardiac Pathways $56.9M Aug 10, 2001
See all 27 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Merus Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors

Competitors

Company Status Description Investors
See all 27 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Audio amplifier using multi-level pulse width modulation Nov 04, 2016 May 22, 2018 Patent
Antibody producing non-human mammals Jan 25, 2013 Apr 24, 2018 Patent
Antibody producing non-human mammals Apr 30, 2014 Apr 17, 2018 Patent
Human cd3 binding antibody Jul 08, 2016 Mar 13, 2018 Patent
Generation of binding molecules Sep 16, 2015 Mar 06, 2018 Patent
See all 49 patents